Total Payments
$158,583
2024 Payments
$166.99
Companies
21
Transactions
267
Medicare Patients
4,307
Medicare Billing
$514,004
Payment Breakdown by Category
Other$133,090 (83.9%)
Travel$10,763 (6.8%)
Consulting$7,825 (4.9%)
Food & Beverage$6,852 (4.3%)
Education$54.23 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130,090 | 49 | 82.0% |
| Travel and Lodging | $10,763 | 64 | 6.8% |
| Consulting Fee | $7,825 | 3 | 4.9% |
| Food and Beverage | $6,852 | 144 | 4.3% |
| Honoraria | $3,000 | 1 | 1.9% |
| Education | $54.23 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $81,810 | 108 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $29,457 | 47 | $0 (2019) |
| Amgen Inc. | $28,906 | 46 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $12,454 | 24 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $4,570 | 7 | $0 (2021) |
| Boston Scientific Corporation | $249.30 | 4 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $169.11 | 9 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $148.33 | 2 | $0 (2017) |
| Akcea Therapeutics, Inc. | $121.36 | 1 | $0 (2020) |
| Biosense Webster, Inc. | $118.19 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.99 | 9 | Novartis Pharmaceuticals Corporation ($65.16) |
| 2023 | $144.43 | 7 | Novartis Pharmaceuticals Corporation ($76.88) |
| 2022 | $14.12 | 1 | Amgen Inc. ($14.12) |
| 2021 | $164.72 | 4 | Kowa Pharmaceuticals America, Inc. ($125.00) |
| 2020 | $25,738 | 51 | Amarin Pharma Inc. ($23,534) |
| 2019 | $82,823 | 116 | Amarin Pharma Inc. ($57,937) |
| 2018 | $32,268 | 47 | Regeneron Healthcare Solutions, Inc. ($17,764) |
| 2017 | $17,264 | 32 | Amgen Inc. ($6,460) |
All Payment Transactions
267 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardio-renal | ||||||
| 05/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 02/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiology | ||||||
| 01/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/28/2023 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 08/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/25/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/19/2023 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/25/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/09/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/29/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiology | ||||||
| 08/27/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiology | ||||||
| 06/29/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 01/27/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Cardiovascular | ||||||
| 01/06/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular | ||||||
| 12/16/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardiovascular | ||||||
| 12/04/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/01/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Cardiovascular | ||||||
| 12/01/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 867 | 1,055 | $327,509 | $95,979 |
| 2022 | 14 | 1,221 | 1,426 | $490,394 | $138,531 |
| 2021 | 15 | 1,229 | 1,604 | $555,630 | $166,534 |
| 2020 | 12 | 990 | 1,217 | $406,289 | $112,961 |
Total Patients
4,307
Total Services
5,302
Medicare Billing
$514,004
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 346 | $125,944 | $37,295 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 167 | $41,249 | $13,824 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $54,292 | $13,215 | 24.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 57 | 57 | $50,331 | $9,526 | 18.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 92 | 100 | $9,600 | $7,326 | 76.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 56 | 60 | $8,280 | $5,880 | 71.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 13 | 30 | $3,240 | $2,600 | 80.2% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 14 | 14 | $13,720 | $2,178 | 15.9% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 29 | 29 | $5,423 | $1,132 | 20.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 13 | 37 | $3,589 | $860.62 | 24.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 13 | 13 | $3,237 | $753.87 | 23.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 48 | $3,984 | $593.38 | 14.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 26 | 27 | $2,727 | $496.36 | 18.2% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 18 | 18 | $1,134 | $198.00 | 17.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 11 | 11 | $759.00 | $101.52 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 258 | 398 | $140,494 | $44,657 | 31.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 164 | 166 | $140,270 | $32,504 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 120 | 120 | $64,560 | $17,092 | 26.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 69 | 82 | $10,988 | $8,549 | 77.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2022 | 40 | 41 | $37,851 | $6,926 | 18.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 88 | 104 | $9,672 | $6,856 | 70.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 63 | $22,554 | $5,802 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 26 | $12,350 | $4,279 | 34.6% |
| 93356 | Heart muscle strain imaging | Office | 2022 | 77 | 78 | $13,806 | $3,068 | 22.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2022 | 92 | 93 | $8,928 | $2,170 | 24.3% |
About Dr. Stephen Raskin, MD
Dr. Stephen Raskin, MD is a Cardiovascular Disease healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730125980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Raskin, MD has received a total of $158,583 in payments from pharmaceutical and medical device companies, with $166.99 received in 2024. These payments were reported across 267 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($130,090).
As a Medicare-enrolled provider, Raskin has provided services to 4,307 Medicare beneficiaries, totaling 5,302 services with total Medicare billing of $514,004. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Oakland, CA
- Active Since 06/22/2006
- Last Updated 03/17/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1730125980
Products in Payments
- Vascepa (Drug) $81,810
- Repatha (Biological) $28,840
- PRALUENT ALIROCUMAB INJECTION (Biological) $23,096
- PRALUENT (Drug) $12,454
- PRALUENT (Biological) $6,510
- Livalo (Drug) $570.06
- TEGSEDI (Drug) $121.36
- Carto 3 System (Device) $118.19
- RESONATE (Device) $108.28
- LifeVest (Device) $106.95
- BRILINTA (Drug) $101.79
- LEQVIO (Drug) $96.12
- WATCHMAN (Device) $86.15
- ENTRESTO (Drug) $72.99
- NEXLETOL (Drug) $71.45
- SQRX PULSE GENERATOR (Device) $54.87
- Kerendia (Drug) $47.22
- ZIO Patch (Device) $40.10
- Hillrom - Cardiac Ambulatory Monitor (Device) $29.78
- XARELTO (Drug) $26.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Oakland
Steven Kang, Md, MD
Cardiovascular Disease — Payments: $632,152
Cardiovascular Disease $632,152
Sam Teichman, Md, MD
Cardiovascular Disease — Payments: $620,961
Cardiovascular Disease $620,961
Michael Tsang, M.d, M.D
Cardiovascular Disease — Payments: $9,340
Cardiovascular Disease $9,340
Luisa Munoz Del Romeral, M.d, M.D
Cardiovascular Disease — Payments: $9,231
Cardiovascular Disease $9,231
Basma Al Bast, Md, MD
Cardiovascular Disease — Payments: $4,833
Cardiovascular Disease $4,833
Dr. Rollington Ferguson, Md, MD
Cardiovascular Disease — Payments: $2,793
Cardiovascular Disease $2,793